Skip to main content
FinSpry Logo
FinSpry
EOLS logo
EOLS
(NASDAQ)
Evolus, Inc.
$8.98-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Evolus (EOLS) Stock Price & Financial Analysis

Evolus Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$8.70 - $9.12
52-Week High$9.12
52-Week Low$3.86
Open$8.72
Volume1.80M
Average Volume (3M)967.96K
Market Cap585.05M
Shares Outstanding65.19M
Price to Sales (P/S)1.94
Price to Book (P/B)-20.33
EV/EBITDA-46.01
Revenue (TTM)301.79M
Net Income (TTM)-43.42M
Free Cash Flow (TTM)-41.33M
EPS (TTM)$-0.67
Profit Margin-14.39%
Operating Margin-9.12%
50-Day MA$6.91
200-Day MA$5.98
52-Week Change20.79%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Evolus

What is the current stock price for EOLS?

As of the latest trading session, EOLS stock trades at $8.97. The 52-week range is $3.86–$9.12, with a day range of $8.70–$9.12.

What is the P/E ratio for EOLS?

The P/E ratio (Price-to-Earnings) for EOLS is shown in the Key Statistics section. This valuation metric helps compare Evolus, Inc. to industry peers.

Does EOLS pay dividends?

Evolus does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EOLS?

Based on 3 analysts, the consensus for EOLS is Buy.

What is the market cap of EOLS?

Evolus's market capitalization is $585.1M, classifying it as a small-cap company. Evolus operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.